<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Virol</journal-id><journal-id journal-id-type="iso-abbrev">J. Med. Virol</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1096-9071</journal-id><journal-id journal-id-type="publisher-id">JMV</journal-id><journal-title-group><journal-title>Journal of Medical Virology</journal-title></journal-title-group><issn pub-type="ppub">0146-6615</issn><issn pub-type="epub">1096-9071</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7461084</article-id><article-id pub-id-type="doi">10.1002/jmv.26450</article-id><article-id pub-id-type="publisher-id">JMV26450</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Articles</subject></subj-group></article-categories><title-group><article-title>Convergence between global BCG vaccination and COVID&#x02010;19 pandemic</article-title><alt-title alt-title-type="left-running-head">ISLAM <sc>et al.</sc></alt-title></title-group><contrib-group><contrib id="jmv26450-cr-0001" contrib-type="author"><name><surname>Islam</surname><given-names>Md. Zahurul</given-names></name><xref ref-type="aff" rid="jmv26450-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jmv26450-cr-0002" contrib-type="author"><name><surname>E&#x02010;Zahan</surname><given-names>Md. Kudrat</given-names></name><xref ref-type="aff" rid="jmv26450-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="jmv26450-cr-0003" contrib-type="author" corresp="yes"><name><surname>Al&#x02010;Bari</surname><given-names>Md. Abdul Alim</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1777-3662</contrib-id><xref ref-type="aff" rid="jmv26450-aff-0003">
<sup>3</sup>
</xref><address><email>alimalbari347@ru.ac.bd</email></address></contrib></contrib-group><aff id="jmv26450-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Applied Mathematics</named-content>
<institution>University of Rajshahi</institution>
<city>Rajshahi</city>
<postal-code>6205</postal-code>
<country country="BD">Bangladesh</country>
</aff><aff id="jmv26450-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Chemistry</named-content>
<institution>University of Rajshahi</institution>
<city>Rajshahi</city>
<postal-code>6205</postal-code>
<country country="BD">Bangladesh</country>
</aff><aff id="jmv26450-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Pharmacy</named-content>
<institution>University of Rajshahi</institution>
<city>Rajshahi</city>
<postal-code>6205</postal-code>
<country country="BD">Bangladesh</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Correspondence Md. Abdul Alim Al&#x02010;Bari, PhD., Professor, Department of Pharmacy, University of Rajshahi, Rajshahi&#x02010;6205, Bangladesh.<break/>
Email: <email>alimalbari347@ru.ac.bd</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>8</month><year>2020</year></pub-date><elocation-id>10.1002/jmv.26450</elocation-id><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 Wiley Periodicals LLC <copyright-statement>--><copyright-statement content-type="article-copyright">This article is protected by copyright. All rights reserved.</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JMV-9999-na.pdf"/><abstract><title>Abstract</title><p>The novel coronavirus SARS&#x02010;CoV&#x02010;2 has kept the whole world in tenterhooks due to its severe life&#x02010;threatening infectious disease, COVID&#x02010;19. The virus is distinct its cousins, SARS&#x02010;CoV and MERS&#x02010;CoV in term of severity of the infection. The obligated killing properties of the SARS&#x02010;CoV&#x02010;2 virus is mediated by its unique structure. Efforts for developing vaccines for COVID&#x02010;19 are ongoing, but it is unlikely to be available in the immediate future. Due to the absence of precise treatment, the investigators are discovering other effective, protective and healing choices. However, the lower than predictable number of SARS&#x02010;CoV&#x02010;2 cases in countries with fragile health systems is mystifying. Recently, there has been a buzz about the protective effect of BCG vaccine in COVID&#x02010;19 through long&#x02010;term boosting of trained immunity. Based on epidemiological correlations, we link up that BCG vaccination adopted by different countries might influence the SARS&#x02010;CoV&#x02010;2 transmission patterns and/or COVID&#x02010;19 associated mortality through the vaccine's capacity to confer heterologous protection. A number of clinical studies are underway to investigate this possibility but &#x02010;even if they prove effective&#x02010;many questions will remain. Moreover, responsible stewardship of the BCG vaccine in the context of the COVID&#x02010;19 epidemic is directly needed.</p><p>This article is protected by copyright. All rights reserved.</p></abstract><kwd-group><kwd id="jmv26450-kwd-0001">BCG vaccination</kwd><kwd id="jmv26450-kwd-0002">correlation data</kwd><kwd id="jmv26450-kwd-0003">COVID&#x02010;19</kwd><kwd id="jmv26450-kwd-0004">severity variation</kwd><kwd id="jmv26450-kwd-0005">trained immunity</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><page-count count="23"/><word-count count="307"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>accepted-manuscript</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.8 mode:remove_FC converted:01.09.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="jmv26450-note-0001"><p>This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/jmv.26450</p></fn></fn-group></notes></front></article>